Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 251.72M | $ 0 | $ -834K | $ 0 | 0.33% |
3/31/2025 | $ 248.7M | $ 0 | $ -409K | $ 0 | 0.16% |
12/31/2024 | $ 257.76M | $ 0 | $ -155K | $ 0 | 0.06% |
9/30/2024 | $ 292.71M | $ 0 | $ 0 | $ 0 | 0% |
6/30/2024 | $ 328.75M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2024 | $ 291.57M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2023 | $ 234.18M | $ 0 | $ 0 | $ 0 | 0% |
9/30/2023 | $ 194.46M | $ 605K | $ 0 | $ 0 | -0.31% |
6/30/2023 | $ 341.6M | $ 609K | $ 0 | $ 0 | -0.18% |
3/31/2023 | $ 367.07M | $ 734K | $ 0 | $ 0 | -0.2% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for VANDA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 6.32M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 601.06M ]
(=) Shareholder Yield [ -1.05% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |